{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:14:27Z","timestamp":1790846067473,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1124\/jpet.117.242735","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T00:50:16Z","timestamp":1501721416000},"page":"35-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome"],"prefix":"10.1016","volume":"363","author":[{"given":"Raymond H.","family":"de Wit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimond","family":"Heukers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik J.","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Arsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maussang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Cutolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrijs","family":"Strubbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry F.","family":"Vischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Bachelerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine J.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.117.242735_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/bjh.12574","article-title":"Genetics on a WHIM","volume":"164","author":"Al Ustwani","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1124\/jpet.117.242735_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1155\/2010\/475104","article-title":"CXCL12\/CXCR4-axis dysfunctions: markers of the rare immunodeficiency disorder WHIM syndrome","volume":"29","author":"Bachelerie","year":"2010","journal-title":"Dis Markers"},{"key":"10.1124\/jpet.117.242735_bib3","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1182\/blood-2012-01-403378","article-title":"Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice","volume":"119","author":"Balabanian","year":"2012","journal-title":"Blood"},{"key":"10.1124\/jpet.117.242735_bib4","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood-2004-06-2289","article-title":"WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12","volume":"105","author":"Balabanian","year":"2005","journal-title":"Blood"},{"key":"10.1124\/jpet.117.242735_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clml.2016.04.014","article-title":"Clinical validation of a CXCR4 mutation screening assay for Waldenstrom macroglobulinemia","volume":"16","author":"Ballester","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1124\/jpet.117.242735_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1172-7-71","article-title":"Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry","volume":"7","author":"Beaussant Cohen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1124\/jpet.117.242735_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.celrep.2016.08.068","article-title":"Efficient plasma cell differentiation and trafficking require Cxcr4 desensitization","volume":"17","author":"Biajoux","year":"2016","journal-title":"Cell Reports"},{"key":"10.1124\/jpet.117.242735_bib8","first-page":"111","article-title":"WHIM syndrome: presumptive diagnosis based on myelokathexis on bone marrow smear","volume":"72","author":"Bock","year":"2014","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1124\/jpet.117.242735_bib9","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/leu.2013.201","article-title":"CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a marker for poor prognosis in acute myeloid leukemia","volume":"28","author":"Brault","year":"2014","journal-title":"Leukemia"},{"key":"10.1124\/jpet.117.242735_bib10","doi-asserted-by":"crossref","first-page":"23736","DOI":"10.1074\/jbc.M000776200","article-title":"Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities","volume":"275","author":"Brelot","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.117.242735_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/leu.2014.187","article-title":"The WHIM-like CXCR4S338X somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom\u2019s macroglobulinemia","volume":"29","author":"Cao","year":"2015","journal-title":"Leukemia"},{"key":"10.1124\/jpet.117.242735_bib12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.chom.2010.11.006","article-title":"A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome","volume":"8","author":"Chow","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1124\/jpet.117.242735_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/363274a0","article-title":"Substitution of three amino acids switches receptor specificity of Gq\u03b1 to that of Gi\u03b1","volume":"363","author":"Conklin","year":"1993","journal-title":"Nature"},{"key":"10.1124\/jpet.117.242735_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/07391102.2016.1145142","article-title":"Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences","volume":"35","author":"Cutolo","year":"2017","journal-title":"J Biomol Struct Dyn"},{"key":"10.1124\/jpet.117.242735_bib15","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/blood-2011-06-360586","article-title":"The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome","volume":"118","author":"Dale","year":"2011","journal-title":"Blood"},{"key":"10.1124\/jpet.117.242735_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd1134","article-title":"The bicyclam AMD3100 story","volume":"2","author":"De Clercq","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.117.242735_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/bs.mie.2015.12.002","article-title":"Molecular pharmacology of chemokine receptors","volume":"570","author":"de Wit","year":"2016","journal-title":"Methods Enzymol"},{"key":"10.1124\/jpet.117.242735_bib18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1200\/JCO.2004.07.131","article-title":"Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin\u2019s lymphoma","volume":"22","author":"Devine","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1124\/jpet.117.242735_bib19","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1074\/jbc.M007734200","article-title":"Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs","volume":"276","author":"Els Conrath","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.117.242735_bib20","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.4049\/jimmunol.160.3.1522","article-title":"Intracellular and surface expression of the HIV-1 coreceptor CXCR4\/fusin on various leukocyte subsets: rapid internalization and recycling upon activation","volume":"160","author":"F\u00f6rster","year":"1998","journal-title":"J Immunol"},{"key":"10.1124\/jpet.117.242735_bib21","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1084\/jem.20160806","article-title":"Lymphoid differentiation of hematopoietic stem cells requires efficient Cxcr4 desensitization","volume":"214","author":"Freitas","year":"2017","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.117.242735_bib22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9","article-title":"WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies","volume":"91","author":"Gorlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1124\/jpet.117.242735_bib23","doi-asserted-by":"crossref","first-page":"37939","DOI":"10.1074\/jbc.C110.147470","article-title":"The peptidomimetic CXCR4 antagonist TC14012 recruits \u03b2-arrestin to CXCR7: roles of receptor domains","volume":"285","author":"Gravel","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.117.242735_bib24","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.44.6.1667-1673.2000","article-title":"Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers","volume":"44","author":"Hendrix","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.117.242735_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1149","article-title":"Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease","volume":"34","author":"Hernandez","year":"2003","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.117.242735_bib26","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","article-title":"The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis","volume":"123","author":"Hunter","year":"2014","journal-title":"Blood"},{"key":"10.1124\/jpet.117.242735_bib27","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00277-002-0489-9","article-title":"Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome. Warts, hypogammaglobulinemia, infections, and myelokathexis","volume":"81","author":"Imashuku","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1124\/jpet.117.242735_bib28","doi-asserted-by":"crossref","first-page":"20565","DOI":"10.1073\/pnas.1012865107","article-title":"CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells","volume":"107","author":"J\u00e4hnichen","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.117.242735_bib29","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1182\/blood-2012-10-461830","article-title":"The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse","volume":"122","author":"Kallikourdis","year":"2013","journal-title":"Blood"},{"key":"10.1124\/jpet.117.242735_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.blre.2015.03.001","article-title":"Waldenstr\u00f6m macroglobulinemia: What a hematologist needs to know","volume":"29","author":"Kapoor","year":"2015","journal-title":"Blood Rev"},{"key":"10.1124\/jpet.117.242735_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MOH.0b013e32831ac557","article-title":"WHIM syndrome: congenital immune deficiency disease","volume":"16","author":"Kawai","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1124\/jpet.117.242735_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood-2007-07-102103","article-title":"CXCR4 dimerization and \u03b2-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome","volume":"112","author":"Lagane","year":"2008","journal-title":"Blood"},{"key":"10.1124\/jpet.117.242735_bib33","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.96.9.5215","article-title":"Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages","volume":"96","author":"Lee","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.117.242735_bib34","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2003-02-0663","article-title":"Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist","volume":"102","author":"Liles","year":"2003","journal-title":"Blood"},{"key":"10.1124\/jpet.117.242735_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood-2011-12-395608","article-title":"WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4","volume":"120","author":"Liu","year":"2012","journal-title":"Blood"},{"key":"10.1124\/jpet.117.242735_bib36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10875-016-0276-3","article-title":"WHIM syndrome caused by Waldenstr\u00f6m\u2019s macroglobulinemia-associated mutation CXCR4L329fs","volume":"36","author":"Liu","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1124\/jpet.117.242735_bib37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1074-7613(00)80046-1","article-title":"The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment","volume":"10","author":"Ma","year":"1999","journal-title":"Immunity"},{"key":"10.1124\/jpet.117.242735_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-pharmtox-010716-104710","article-title":"Nanobodies to study G protein-coupled receptor structure and function","volume":"57","author":"Manglik","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.117.242735_bib39","doi-asserted-by":"crossref","first-page":"29562","DOI":"10.1074\/jbc.M113.498436","article-title":"Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo","volume":"288","author":"Maussang","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.117.242735_bib40","doi-asserted-by":"crossref","first-page":"e8102.","DOI":"10.1371\/journal.pone.0008102","article-title":"Impaired recruitment of Grk6 and \u03b2-arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor","volume":"4","author":"McCormick","year":"2009","journal-title":"PLoS One"},{"key":"10.1124\/jpet.117.242735_bib41","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.cell.2015.01.014","article-title":"Chromothriptic cure of WHIM syndrome","volume":"160","author":"McDermott","year":"2015","journal-title":"Cell"},{"key":"10.1124\/jpet.117.242735_bib42","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2011-07-368084","article-title":"The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome","volume":"118","author":"McDermott","year":"2011","journal-title":"Blood"},{"key":"10.1124\/jpet.117.242735_bib43","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood-2013-09-527226","article-title":"A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor","volume":"123","author":"McDermott","year":"2014","journal-title":"Blood"},{"key":"10.1124\/jpet.117.242735_bib45","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1582-4934.2010.01210.x","article-title":"AMD3100 is a potent antagonist at CXCR4R334X, a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome","volume":"15","author":"McDermott","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1124\/jpet.117.242735_bib46","doi-asserted-by":"crossref","first-page":"e1006039.","DOI":"10.1371\/journal.ppat.1006039","article-title":"The CXCL12\/CXCR4 signaling pathway: a new susceptibility factor in human papillomavirus pathogenesis","volume":"12","author":"Meuris","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1124\/jpet.117.242735_bib47","doi-asserted-by":"crossref","first-page":"e64975.","DOI":"10.1371\/journal.pone.0064975","article-title":"Hierarchical organization of multi-site phosphorylation at the CXCR4 C terminus","volume":"8","author":"Mueller","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.117.242735_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tips.2014.03.003","article-title":"GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics","volume":"35","author":"Muji\u0107-Deli\u0107","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.117.242735_bib49","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2013.08.298","article-title":"Targeting tumors with nanobodies for cancer imaging and therapy","volume":"172","author":"Oliveira","year":"2013","journal-title":"J Control Release"},{"key":"10.1124\/jpet.117.242735_bib50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1505533","article-title":"Caplacizumab for acquired thrombotic thrombocytopenic Purpura","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.117.242735_bib51","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2014-03-564583","article-title":"C1013G\/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma","volume":"123","author":"Roccaro","year":"2014","journal-title":"Blood"},{"key":"10.1124\/jpet.117.242735_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00262-006-0180-4","article-title":"Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR nanobodies","volume":"56","author":"Roovers","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1124\/jpet.117.242735_bib53","first-page":"155","article-title":"Affinity and avidity in antibody-based tumor targeting","volume":"24","author":"Rudnick","year":"2009","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1124\/jpet.117.242735_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1008000327766","article-title":"Transient gene expression in mammalian cells grown in serum-free suspension culture","volume":"30","author":"Schlaeger","year":"1999","journal-title":"Cytotechnology"},{"key":"10.1124\/jpet.117.242735_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/14756360290024227","article-title":"Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents","volume":"17","author":"Scozzafava","year":"2002","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1124\/jpet.117.242735_bib56","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.sbi.2011.06.011","article-title":"Nanobody stabilization of G protein-coupled receptor conformational states","volume":"21","author":"Steyaert","year":"2011","journal-title":"Curr Opin Struct Biol"},{"key":"10.1124\/jpet.117.242735_bib57","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1158\/1535-7163.MCT-07-2384","article-title":"Improved tumor targeting of anti-epidermal growth factor receptor nanobodies through albumin binding: taking advantage of modular nanobody technology","volume":"7","author":"Tijink","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/jpet.117.242735_bib58","doi-asserted-by":"crossref","first-page":"135.","DOI":"10.1186\/s13075-015-0651-0","article-title":"The preclinical pharmacology of the high affinity anti-IL-6R Nanobody\u00ae ALX-0061 supports its clinical development in rheumatoid arthritis","volume":"17","author":"Van Roy","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1124\/jpet.117.242735_bib59","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/bph.12106","article-title":"Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands","volume":"168","author":"Vauquelin","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.117.242735_bib60","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1074\/jbc.273.24.15007","article-title":"CXCR4 sequences involved in coreceptor determination of human immunodeficiency virus type-1 tropism. Unmasking of activity with M-tropic Env glycoproteins","volume":"273","author":"Wang","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.117.242735_bib61","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1073\/pnas.1601278113","article-title":"Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices","volume":"113","author":"Wescott","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.117.242735_bib62","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jdv.12927","article-title":"Primary cutaneous follicle center lymphoma in a patient with WHIM syndrome","volume":"30","author":"Yoshii","year":"2015","journal-title":"J Euro Acad Dermatol Venereol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524271676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524271676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.117.242735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:09:03Z","timestamp":1739995743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524271676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0022356524271676"],"URL":"https:\/\/doi.org\/10.1124\/jpet.117.242735","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.117.242735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}